{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:27:51Z","timestamp":1789140471453,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Scientific Research Fund of Yunnan Provincial Department of Education","award":["2022J0142"],"award-info":[{"award-number":["2022J0142"]}]},{"name":"Basic Research Project of Yunnan Provincial Department of Science and Technology","award":["202201AY070001-163"],"award-info":[{"award-number":["202201AY070001-163"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gynecological cancer will become a more important public health problem in future years but limited evidence on gynecological cancer burden in China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We extracted age-specific rate of cancer cases and deaths during 2007\u20132016 from the Chinese Cancer Registry Annual Report, and estimated age-specific population size using the data released by National Bureau of Statistics of China. Cancer burden were calculated by multiplying the rates with the population size. Temporal trends of the cancer cases, incidence, deaths, and mortality during 2007\u20132016 were calculated by JoinPoint Regression Program, and from 2017 to 2030 were projected by grey prediction model GM\u00a0(1,1).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In China, total gynecological cancer cases increased from 177,839 to 241,800, with the average annual percentage change of 3.5% (95%\u00a0CI: 2.7\u20134.3%) during 2007\u20132016. Cervical, uterine, ovarian, vulva, and other gynecological cancer cases increased by 4.1% (95%\u00a0CI: 3.3\u20134.9%), 3.3% (95%\u00a0CI: 2.6\u20134.1%), 2.4% (95%\u00a0CI: 1.4\u20133.5%), 4.4% (95%\u00a0CI: 2.5\u20136.4%), and 3.6% (95%\u00a0CI: 1.4\u20135.9%) respectively. From 2017 to 2030, projected gynecological cancer cases are changing from 246,581 to 408,314. Cervical, vulva and vaginal cancers showed evident upward trend, while uterine and ovarian cancer cases are slightly increasing. The increases for age-standardized incidence rates were similar with that of cancer cases. Temporal trends of cancer deaths and mortality were similar with that of cancer cases and incidence during 2007\u20132030, except that uterine cancer deaths and mortality were declined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>With the aging of population and other increased risk factors, the burden of gynecological cancers in China is likely to be grew rapidly in the future, comprehensive gynecological cancer control should be concerned.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02384-2","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T10:02:37Z","timestamp":1688119357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Temporal trends and projections of gynecological cancers in China, 2007\u20132030"],"prefix":"10.1186","volume":"23","author":[{"given":"Rufei","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Tang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"issue":"6","key":"2384_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"Cancer J Clin"},{"issue":"2","key":"2384_CR2","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global health. 2020;8(2):e191\u2013e203.","journal-title":"The Lancet Global health"},{"key":"2384_CR3","doi-asserted-by":"crossref","unstructured":"Zhang Y, Luo G, Li M, Guo P, Xiao Y, Ji H et al. Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis. 2019;19(1):984.","DOI":"10.1186\/s12885-019-6139-6"},{"key":"2384_CR4","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Weiderpass E. Geographic and temporal variations in the incidence of vulvar and vaginal cancers. 2020;147(10):2764\u201371.","DOI":"10.1002\/ijc.33055"},{"key":"2384_CR5","doi-asserted-by":"crossref","unstructured":"Huang J, Chan WC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE. 3rd, Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study. Cancers. 2022;14(9).","DOI":"10.3390\/cancers14092230"},{"issue":"2","key":"2384_CR6","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S2214-109X(18)30488-1","volume":"7","author":"W Chen","year":"2019","unstructured":"Chen W, Xia C, Zheng R, Zhou M, Lin C, Zeng H, et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. The Lancet Global health. 2019;7(2):e257\u2013e69.","journal-title":"The Lancet Global health"},{"key":"2384_CR7","unstructured":"WHO. WHO Director-. General calls for all countries to take action to help end the suffering caused by cervical cancer 2018 [cited 2021 Apr 10]. Available from: https:\/\/www.who.int\/reproductivehealth\/call-to-action-elimination-cervical-cancer\/en\/."},{"issue":"12","key":"2384_CR8","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1002\/ijc.32514","volume":"145","author":"L Costas","year":"2019","unstructured":"Costas L, Frias-Gomez J, Guardiola M, Benavente Y, Pineda M, Pav\u00f3n M, et al. New perspectives on screening and early detection of endometrial cancer. Int J Cancer. 2019;145(12):3194\u2013206.","journal-title":"Int J Cancer"},{"issue":"1","key":"2384_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12905-022-02104-2","volume":"22","author":"X Han","year":"2022","unstructured":"Han X, Wang Z, Huang D, Deng K, Wang Q, Li C, et al. Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020. BMC Womens Health. 2022;22(1):504.","journal-title":"BMC Womens Health"},{"issue":"2","key":"2384_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ygyno.2021.08.029","volume":"163","author":"Z Wang","year":"2021","unstructured":"Wang Z, Guo E, Yang B, Xiao R, Lu F, You L, et al. Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: cervical, ovarian and uterine cancer. Gynecol Oncol. 2021;163(2):358\u201363.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2384_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"Cancer J Clin"},{"key":"2384_CR12","unstructured":"NCC. 2019 China Cancer Registry Annual Report. Beijing: People\u2019s Medical Publishing House; 2021."},{"issue":"3","key":"2384_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351.","journal-title":"Stat Med"},{"issue":"5","key":"2384_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0167-6911(82)80025-X","volume":"1","author":"JL Deng","year":"1982","unstructured":"Deng JL. Control problems of grey systems. Syst Control Lett. 1982;1(5):288\u201394.","journal-title":"Syst Control Lett"},{"issue":"1","key":"2384_CR15","first-page":"117","volume":"38","author":"HM Qu","year":"2017","unstructured":"Qu HM, Bai YN, Kui FR, Hu XB, Pei HB, Ren XW, et al. [Effect of combination model on fitting cancer mortality and prediction]. Zhonghua liu xing bing xue za zhi = Zhonghua. liuxingbingxue zazhi. 2017;38(1):117\u201320.","journal-title":"liuxingbingxue zazhi"},{"key":"2384_CR16","unstructured":"Wang JF, Lin WY, Jiang F, Meng W, Shen FM. [Analysis of time trend of hepatocellular carcinoma mortality in Haimen city of Jiangsu province from 1993 to 2006]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2010;31(7):727\u201332."},{"issue":"1","key":"2384_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","volume":"2","author":"R Zheng","year":"2022","unstructured":"Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent. 2022;2(1):1\u20139.","journal-title":"J Natl Cancer Cent"},{"issue":"2","key":"2384_CR18","doi-asserted-by":"publisher","first-page":"e019005","DOI":"10.1136\/bmjopen-2017-019005","volume":"8","author":"BT Hansen","year":"2018","unstructured":"Hansen BT, Campbell S, Nygard M. Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway. BMJ open. 2018;8(2):e019005.","journal-title":"BMJ open"},{"issue":"33","key":"2384_CR19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.15585\/mmwr.mm6733a2","volume":"67","author":"EA Van Dyne","year":"2018","unstructured":"Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in Human Papillomavirus-Associated Cancers - United States, 1999\u20132015. MMWR Morbidity and mortality weekly report. 2018;67(33):918\u201324.","journal-title":"MMWR Morbidity and mortality weekly report"},{"key":"2384_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2016.04.016","volume":"63","author":"Z Huang","year":"2016","unstructured":"Huang Z, Zheng Y, Wen W, Wu C, Bao P, Wang C, et al. Incidence and mortality of gynaecological cancers: secular trends in urban Shanghai, China over 40 years. Eur J cancer (Oxford England: 1990). 2016;63:1\u201310.","journal-title":"Eur J cancer (Oxford England: 1990)"},{"key":"2384_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fpubh.2016.00146","volume":"4","author":"Z Teng","year":"2016","unstructured":"Teng Z, Han R, Huang X, Zhou J, Yang J, Luo P, et al. Increase of incidence and mortality of Ovarian Cancer during 2003\u20132012 in Jiangsu Province, China. Front public health. 2016;4:146.","journal-title":"Front public health"},{"issue":"6","key":"2384_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1001\/jama.2017.21421","volume":"319","author":"JT Henderson","year":"2018","unstructured":"Henderson JT, Webber EM, Sawaya GF. Screening for ovarian Cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;319(6):595\u2013606.","journal-title":"JAMA"},{"key":"2384_CR23","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3389\/fonc.2019.01440","volume":"9","author":"S Zhang","year":"2019","unstructured":"Zhang S, Gong TT, Liu FH, Jiang YT, Sun H, Ma XX, et al. Global, Regional, and National Burden of Endometrial Cancer, 1990\u20132017: results from the global burden of Disease Study, 2017. Front Oncol. 2019;9:1440.","journal-title":"Front Oncol"},{"issue":"4","key":"2384_CR24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/jnci\/djx214","volume":"110","author":"J Lortet-Tieulent","year":"2018","unstructured":"Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. International patterns and Trends in Endometrial Cancer incidence, 1978\u20132013. J Natl Cancer Inst. 2018;110(4):354\u201361.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"2384_CR25","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ijc.31961","volume":"145","author":"O Raglan","year":"2019","unstructured":"Raglan O, Kalliala I, Markozannes G, Cividini S, Gunter MJ, Nautiyal J, et al. Risk factors for endometrial cancer: an umbrella review of the literature. Int J Cancer. 2019;145(7):1719\u201330.","journal-title":"Int J Cancer"},{"key":"2384_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bpobgyn.2019.12.006","volume":"65","author":"A Gentry-Maharaj","year":"2020","unstructured":"Gentry-Maharaj A, Karpinskyj C. Current and future approaches to screening for endometrial cancer. Best Pract Res Clin Obstet Gynecol. 2020;65:79\u201397.","journal-title":"Best Pract Res Clin Obstet Gynecol"},{"issue":"1","key":"2384_CR27","doi-asserted-by":"publisher","first-page":"e062091","DOI":"10.1136\/bmjopen-2022-062091","volume":"13","author":"Z Liang","year":"2023","unstructured":"Liang Z, Wu D, Guo C, Gu J. Temporal trend of population structure, burden of diseases, healthcare resources and expenditure in China, 2000\u20132019. BMJ open. 2023;13(1):e062091.","journal-title":"BMJ open"},{"key":"2384_CR28","unstructured":"PUMCH. Ethical Requirements and Management Standard for the Sharing and Use of Medical Scientific Data. Chinese Medical Ethics. 2020;33 (06)."}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02384-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02384-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02384-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T10:03:42Z","timestamp":1688119422000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02384-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2384"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02384-2","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,30]]},"assertion":[{"value":"27 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a secondary analysis of data available in the Chinese Cancer Registry Annual Report and National Bureau of Statistics of China. According to the Ethical Requirements and Management Standard for the Sharing and Use of Medical Scientific Data [], this study did not need ethical approval. Consent to participant is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participant"}},{"value":"This study followed the EQUATOR network guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Enhancing the quality and transparency of health research (EQUATOR) network guidelines"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}